Litcius/Paper detail

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, Denise Kviatcovsky, Eyal Weinstock, Yulia Matiuhin, Yael Silberberg, Koji Atarashi, Munehiro Furuichi, Akihiko Oka, Bo Liu, Morine Fibelman, Iddo Weiner, Efrat Khabra, Nyssa Cullin, Noa Ben-Yishai, Dana Inbar, Hava Ben‐David, Julian Nicenboim, Noga Kowalsman, Wolfgang Lieb, Edith Kario, Tal Cohen, Yael Friedman Geffen, Lior Zelcbuch, Ariel Cohen, Urania Rappo, Inbar Gahali-Sass, Myriam Golembo, Vered Lev, Mally Dori-Bachash, Hagit Shapiro, Claudia Moresi, Amanda Cuevas‐Sierra, Gayatree Mohapatra, Lara Kern, Danping Zheng, Samuel Philip Nobs, Jotham Suez, Noa Stettner, Alon Harmelin, Naomi B. Zak, Sailaja Puttagunta, Merav Bassan, Kenya Honda, Harry Sokol, Corinna Bang, André Franke, Christoph Schramm, Nitsan Maharshak, R. Balfour Sartor, Rotem Sorek, Eran Elinav

2022Cell514 citationsDOIOpen Access PDF

Topics & Concepts

BiologyPhage therapyLytic cycleCommensalismInflammatory bowel diseaseMicrobiologyImmunologyGut floraInflammationColitisAntibioticsDiseaseVirologyBacteriaVirusEscherichia coliGeneBacteriophageMedicineGeneticsInternal medicineBacteriophages and microbial interactionsViral gastroenteritis research and epidemiologyClostridium difficile and Clostridium perfringens research
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation | Litcius